FDA approves treatment for people with mild forms of Alzheimer’s By: MarketWatch January 06, 2023 at 14:47 PM EST Leqembi, which was developed by Eisai and Biogen, will cost about $26,000 a year Read More >> Related Stocks: Biogen Idec Eisai Ltd ADR
